Hospira Inc. recalls KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Fores
Recalled July 22, 2015 · FDA recall D-1242-2015 · Hospira
Hazard
Crystallization; identified as calcium salt of Ketorolac · FDA Class II
Units
5,214,900 vials (Hospira label); 250,600 vials (NOVAPLUS label)
Sold at
Nationwide, Puerto Rico, Guam, Canada and Singapore
Description
Crystallization; identified as calcium salt of Ketorolac
Product
KETOROLAC Tromethamine Inj., USP, 60 mg (30 mg/mL), 2 mL Fill Single-dose Vials, I.V/I.M. USE, Hospira, Inc., Lake Forest, IL 60045 --- NDC 0409-3796-01 ---- ALSO labeled under NOVAPLUS label NDC 0409-3796-49
Manufacturer(s)
Hospira Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →